TipRanks
Human Health Holdings Ltd. (HK:1419)
:1419
Hong Kong Market
1419
Human Health Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:1419 full AI Analyst Report?

Human Health Holdings Ltd. (1419) Ratios

1 Followers

Human Health Holdings Ltd. Ratios

HK:1419's free cash flow for Q4 2025 was HK$0.56. For the 2025 fiscal year, HK:1419's free cash flow was decreased by HK$ and operating cash flow was HK$0.05. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 3.03 3.03 2.88 2.84 2.28
Quick Ratio
 2.94 2.94 2.76 2.69 2.20
Cash Ratio
 2.52 2.52 2.16 2.27 1.84
Solvency Ratio
 0.35 0.35 0.32 0.32 0.56
Operating Cash Flow Ratio
 0.33 0.00 0.48 0.05 1.90
Short-Term Operating Cash Flow Coverage
 1.90 0.00 5.78 0.36 18.19
Net Current Asset Value
HK$ 356.93MHK$ 356.93MHK$ 297.43MHK$ 323.91MHK$ 341.72M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.13 0.14 0.14
Debt-to-Equity Ratio
 0.17 0.17 0.17 0.19 0.23
Debt-to-Capital Ratio
 0.14 0.14 0.15 0.16 0.18
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.34 1.37 1.38 1.56
Debt Service Coverage Ratio
 2.44 2.44 4.10 2.56 5.93
Interest Coverage Ratio
 11.25 16.34 15.13 2.18 37.01
Debt to Market Cap
 0.12 0.13 0.05 0.08 0.05
Interest Debt Per Share
 0.36 0.37 0.37 0.41 0.50
Net Debt to EBITDA
 -3.68 -3.68 -3.08 -3.30 -1.42
Profitability Margins
Gross Profit Margin
46.35%46.35%46.02%45.67%59.22%
EBIT Margin
5.85%5.85%4.87%6.07%24.80%
EBITDA Margin
15.81%15.81%15.38%17.61%32.29%
Operating Profit Margin
10.88%15.81%15.38%3.04%30.65%
Pretax Profit Margin
4.64%4.64%4.65%4.50%23.84%
Net Profit Margin
4.04%4.04%4.09%4.09%18.05%
Continuous Operations Profit Margin
4.22%4.22%4.13%4.09%18.05%
Net Income Per EBT
87.08%87.08%87.96%91.06%75.72%
EBT Per EBIT
42.63%29.34%30.21%148.05%77.77%
Return on Assets (ROA)
2.54%2.54%2.46%2.29%14.31%
Return on Equity (ROE)
3.43%3.41%3.37%3.16%22.38%
Return on Capital Employed (ROCE)
8.51%12.36%11.41%2.13%33.59%
Return on Invested Capital (ROIC)
7.02%10.19%9.44%1.77%25.93%
Return on Tangible Assets
2.75%2.75%2.66%2.37%14.73%
Earnings Yield
9.25%9.73%8.36%6.07%25.08%
Efficiency Ratios
Receivables Turnover
 13.53 13.53 10.32 13.52 9.86
Payables Turnover
 6.29 6.29 4.89 6.22 7.12
Inventory Turnover
 19.08 19.08 13.87 9.94 14.42
Fixed Asset Turnover
 3.38 3.38 2.90 2.86 4.52
Asset Turnover
 0.63 0.63 0.60 0.56 0.79
Working Capital Turnover Ratio
 1.61 1.67 1.65 1.40 2.28
Cash Conversion Cycle
 -11.91 -11.91 -13.02 4.98 11.09
Days of Sales Outstanding
 26.98 26.98 35.37 27.00 37.03
Days of Inventory Outstanding
 19.13 19.13 26.31 36.71 25.31
Days of Payables Outstanding
 58.02 58.02 74.70 58.73 51.25
Operating Cycle
 46.11 46.11 61.68 63.71 62.34
Cash Flow Ratios
Operating Cash Flow Per Share
 0.18 0.00 0.26 0.03 1.75
Free Cash Flow Per Share
 0.17 0.00 0.24 -0.07 1.53
CapEx Per Share
 <0.01 0.00 0.02 0.10 0.22
Free Cash Flow to Operating Cash Flow
 0.96 0.00 0.92 -2.48 0.87
Dividend Paid and CapEx Coverage Ratio
 28.30 0.00 5.29 0.11 3.36
Capital Expenditure Coverage Ratio
 28.30 0.00 12.53 0.29 7.91
Operating Cash Flow Coverage Ratio
 0.51 0.00 0.72 0.08 3.64
Operating Cash Flow to Sales Ratio
 0.10 0.00 0.15 0.02 0.66
Free Cash Flow Yield
22.89%0.00%28.42%-7.07%80.46%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.63 10.21 11.96 16.48 3.99
Price-to-Sales (P/S) Ratio
 0.43 0.42 0.49 0.67 0.72
Price-to-Book (P/B) Ratio
 0.37 0.35 0.40 0.52 0.89
Price-to-Free Cash Flow (P/FCF) Ratio
 4.37 0.00 3.52 -14.15 1.24
Price-to-Operating Cash Flow Ratio
 4.28 0.00 3.24 35.14 1.09
Price-to-Earnings Growth (PEG) Ratio
 3.35 3.37 1.34 -0.19 -0.08
Enterprise Value Multiple
 -0.96 -1.05 0.10 0.53 0.81
Enterprise Value
 -101.75M -111.30M 9.67M 55.41M 262.38M
EV to EBITDA
 -0.96 -1.05 0.10 0.53 0.81
EV to Sales
 -0.15 -0.17 0.01 0.09 0.26
EV to Free Cash Flow
 -1.54 0.00 0.11 -1.97 0.45
EV to Operating Cash Flow
 -1.49 0.00 0.10 4.89 0.39
Tangible Book Value Per Share
 1.85 1.87 1.85 1.93 2.04
Shareholders’ Equity Per Share
 2.06 2.08 2.06 2.02 2.13
Tax and Other Ratios
Effective Tax Rate
 0.09 0.09 0.11 0.09 0.24
Revenue Per Share
 1.74 1.76 1.70 1.56 2.64
Net Income Per Share
 0.07 0.07 0.07 0.06 0.48
Tax Burden
 0.87 0.87 0.88 0.91 0.76
Interest Burden
 0.79 0.79 0.95 0.74 0.96
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.31 0.31 0.31 0.31 0.21
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 2.52 0.00 3.69 0.47 3.67
Currency in HKD